Shaji K Kumar

Shaji K Kumar

UNVERIFIED PROFILE

Are you Shaji K Kumar?   Register this Author

Register author
Shaji K Kumar

Shaji K Kumar

Publications by authors named "Shaji K Kumar"

Are you Shaji K Kumar?   Register this Author

100Publications

2183Reads

50Profile Views

Stem-cell transplantation in multiple myeloma: how far have we come?

Ther Adv Hematol 2019 14;10:2040620719888111. Epub 2019 Nov 14.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719888111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859676PMC
November 2019

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma.

Haematologica 2019 Oct 7;104(10):2061-2074. Epub 2019 Mar 7.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.211110DOI Listing
October 2019

Recycling therapies for myeloma: The need for prospective trials.

Authors:
Shaji K Kumar

Cancer 2019 Sep 15;125(17):2920-2922. Epub 2019 May 15.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32177DOI Listing
September 2019

Time Horizons in Cost Analyses.

JAMA 2019 08;322(6):582-583

Centre for Health Economics, University of York, York, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.7853DOI Listing
August 2019

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.

Biol Blood Marrow Transplant 2019 03 7;25(3):e108-e111. Epub 2018 Dec 7.

Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445701PMC
March 2019

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 Feb 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.

Blood 2019 02 26;133(7):652-659. Epub 2018 Dec 26.

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-08-825349DOI Listing
February 2019

The stepchild in myeloma treatments: is allogeneic transplantation not so bad after all?

Haematologica 2019 Feb;104(2):222-225

Department of Oncology/Hematology, A.O.U. Città della Salute e della Scienza di Torino, Presidio Molinette, Torino, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355504PMC
February 2019

Validation of Mayo Clinic Staging System for Light Chain Amyloidosis With High-Sensitivity Troponin.

J Clin Oncol 2019 01 15;37(2):171-173. Epub 2018 Nov 15.

Shaji K. Kumar, MD; Morie A. Gertz, MD; and Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.01398DOI Listing
January 2019

Targeted Management Strategies in Multiple Myeloma.

Authors:
Shaji K Kumar

Cancer J 2019 Jan/Feb;25(1):59-64

From the Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000353DOI Listing
January 2019

Ixazomib for the treatment of multiple myeloma.

Expert Opin Pharmacother 2018 Dec 13;19(17):1949-1968. Epub 2018 Nov 13.

g Hematology & Medical Oncology , Winship Cancer Institute, Emory University , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14656566.2018.1
Publisher Site
http://dx.doi.org/10.1080/14656566.2018.1528229DOI Listing
December 2018

Timing of treatment of smoldering myeloma: delay until progression.

Authors:
Shaji K Kumar

Blood Adv 2018 11;2(21):3050-3053

Division of Hematology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018021238DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234369PMC
November 2018

Should we measure clonal circulating plasma cells in light chain amyloidosis?

Oncotarget 2018 Nov 2;9(86):35607-35608. Epub 2018 Nov 2.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235020PMC
November 2018

Response to 'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'.

Leukemia 2018 09 25;32(9):2083-2085. Epub 2018 May 25.

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0155-4DOI Listing
September 2018

Minimal residual disease analysis in myeloma - when, why and where.

Leuk Lymphoma 2018 08 11;59(8):1772-1784. Epub 2017 Oct 11.

b Department of Internal Medicine, Division of Hematology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1386304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208356PMC
August 2018

Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2018 08 4;24(8):1546-1553. Epub 2018 Apr 4.

Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183016
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.03.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108907PMC
August 2018

The multiple myelomas - current concepts in cytogenetic classification and therapy.

Nat Rev Clin Oncol 2018 07;15(7):409-421

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0018-yDOI Listing
July 2018

Monoclonal Antibodies for Myeloma: Make It Easy!

Authors:
Shaji K Kumar

J Oncol Pract 2018 07;14(7):423-424

Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00350DOI Listing
July 2018

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response.

Leukemia 2018 05 30;32(5):1243-1246. Epub 2018 Jan 30.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0022-3DOI Listing
May 2018

Management of Multiple Myeloma.

Authors:
Shaji K Kumar

J Natl Compr Canc Netw 2018 05;16(5S):624-627

Presented by Shaji K. Kumar, MD, Division of Hematology, Mayo Clinic Cancer Center, Rochester, Minnesota.

View Article

Download full-text PDF

Source
https://jnccn.org/doi/10.6004/jnccn.2018.0040
Publisher Site
http://dx.doi.org/10.6004/jnccn.2018.0040DOI Listing
May 2018

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.

Leuk Lymphoma 2018 02 8;59(2):288-299. Epub 2017 Jun 8.

a Division of Hematology , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1334124DOI Listing
February 2018

Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).

Eur J Haematol 2018 Feb 16;100(2):215-217. Epub 2017 Nov 16.

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12986DOI Listing
February 2018

Checking in: T cells against multiple myeloma.

Authors:
Shaji K Kumar

Blood 2017 09;130(10):1175-1176

MAYO CLINIC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-05-783647DOI Listing
September 2017

Multiple myeloma.

Nat Rev Dis Primers 2017 Jul 20;3:17046. Epub 2017 Jul 20.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.46DOI Listing
July 2017

Highlights of Multiple Myeloma at the Annual Meeting of American Society of Hematology, 2016.

Indian J Hematol Blood Transfus 2017 Jun 28;33(2):153-158. Epub 2017 Feb 28.

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55906 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12288-017-0796-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442069PMC
June 2017

New Treatment Options for the Management of Multiple Myeloma.

Authors:
Shaji K Kumar

J Natl Compr Canc Netw 2017 05;15(5S):709-712

Presented by Shaji K. Kumar, MD, Division of Hematology, Mayo Clinic Cancer Center, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0080DOI Listing
May 2017

Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States.

Blood Adv 2017 Jan 4;1(4):282-287. Epub 2017 Jan 4.

Division of Molecular & Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2016002493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727774PMC
January 2017